Allphase Pharma Consulting, LLC
A Professional Service Provider for the Pharma Industry
Hansa is a small Swedish company with a unique product, a protease from Strep. pyogenes that cleaves IgG called Imlifidase, Idefirix or IdeS for short. They steered IdeS through a difficult early development, obtained approval for their drug in many EU countries for ‘desensitisation treatment of highly sensitised adult kidney transplant Continue reading HANSA, Where is the Beef?
As the 2017 Holiday Season [1] is upon us, here some concepts to ponder while in the mood. Certainly not strategic imperatives, just musings and thoughts for discussion: #1: Consider developing your inhaled antibiotic in CF first. Pursuing a new indication is high risk, akin to playing Russian roulette but with Continue reading Aerosolized Antibiotics (Part 3) – How To Avoid Hitting A Wall
When you search for ‘ceftidoren’ on Wikipedia, you will get a surprise: there is no entry. However, a search on the web tells us that Spectracef (ceftidoren pivoxil) still exists. Gee, now the drug is spelled ‘cefditoren’ and – looking through the list of retrieved articles – it seems that Continue reading Choose your Outcome: How Design Minutiae Affect Trial Results